For best experience please turn on javascript and use a modern browser!
You are using a browser that is no longer supported by Microsoft. Please upgrade your browser. The site may not present itself correctly if you continue browsing.
Bekijk de site in het Nederlands

Since the discovery of HIV-1 as a cause of aids, many antiretroviral pharmaceuticals have been developed to target viral replication. The combination of at least three antiretroviral drugs, preferably from at least two different classes, has become standard practice and is known as Highly Active Anti-Retroviral Treatment (HAART). However, despite the success of the treatment, patients do often suffer drug-induced adverse events, some of which can be life threatening. The aim of Ruben Smith’s research is to clarify the short term effects of antiretroviral drugs in order to understand the mechanisms underlying the toxicity that causes such adverse events.

Event details of Adverse effects in HIV treatment
Date 12 February 2016
Time 14:00 -15:00
Location Agnietenkapel
Room Location

R.L. Smith: Towards an Understanding of the Side Effects of Anti-HIV Drugs Using Caenorhabditis Elegans.

Supervisor

Prof. S. Brul

Co-supervisor

Dr J.C. van der Spek

Agnietenkapel

Room Location

Oudezijds Voorburgwal 229 - 231
1012 EZ Amsterdam

Entrance

This event is open to the public.